These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 20591770)

  • 1. FDA new drug approvals in 2009.
    Wynn RL
    Gen Dent; 2010; 58(4):280-4. PubMed ID: 20591770
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA new drug approvals in 2005.
    Wynn RL
    Gen Dent; 2006; 54(4):230-3. PubMed ID: 16903192
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA new drug approvals in 2007.
    Wynn RL
    Gen Dent; 2008; 56(6):506-10. PubMed ID: 18810906
    [No Abstract]   [Full Text] [Related]  

  • 4. New drug approvals in 2000.
    Wynn RL
    Gen Dent; 2001; 49(4):341-5. PubMed ID: 12016673
    [No Abstract]   [Full Text] [Related]  

  • 5. New drugs and product approvals from 2000.
    Taylor SE; Gage TW
    Tex Dent J; 2001 Nov; 118(11):1070-81. PubMed ID: 11806330
    [No Abstract]   [Full Text] [Related]  

  • 6. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed accelerated FDA approvals for special medical use.
    Somberg JC
    Am J Ther; 2012 Nov; 19(6):393-4. PubMed ID: 23154227
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA new drug approvals in 2003.
    Wynn RL
    Gen Dent; 2004; 52(4):294-8, 300. PubMed ID: 15366292
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA new drug approvals in 2006.
    Wynn RL
    Gen Dent; 2007; 55(4):275-9. PubMed ID: 17682633
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA new drug approvals in 2004.
    Wynn RL
    Gen Dent; 2005; 53(4):246-8. PubMed ID: 16158789
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA approvals. New drugs, new uses.
    Rodman MJ
    RN; 1991 Mar; 54(3):61-8. PubMed ID: 2003204
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA new drug approvals in 2008.
    Wynn RL
    Gen Dent; 2009; 57(4):300-4. PubMed ID: 19903606
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA drug approvals from 1994 to 1995.
    Wynn RL
    Gen Dent; 1996; 44(2):114, 116, 118. PubMed ID: 8690259
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA drug approvals in 1993-94.
    Wynn RL
    Gen Dent; 1995; 43(1):12, 14. PubMed ID: 7758913
    [No Abstract]   [Full Text] [Related]  

  • 15. The FDA's classification system for new drugs. An evaluation of therapeutic gain.
    Finkel MJ
    N Engl J Med; 1980 Jan; 302(3):181-3. PubMed ID: 7350458
    [No Abstract]   [Full Text] [Related]  

  • 16. Beware of new drugs, study suggests.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 May; 13(10):1-2, 5. PubMed ID: 12492085
    [No Abstract]   [Full Text] [Related]  

  • 17. Significant FDA approvals in 2000.
    McGinnis TJ
    Am Fam Physician; 2001 May; 63(10):2061-4. PubMed ID: 11388719
    [No Abstract]   [Full Text] [Related]  

  • 18. Significant FDA approvals in 1996.
    Rheinstein PH
    Am Fam Physician; 1997 Jun; 55(8):2855-8. PubMed ID: 9191461
    [No Abstract]   [Full Text] [Related]  

  • 19. Turning a blind eye.
    Nat Med; 2008 Jan; 14(1):1. PubMed ID: 18180702
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA drug information that never reaches clinicians.
    Messerli FH; Bangalore S
    N Engl J Med; 2010 Feb; 362(6):562; author reply 563. PubMed ID: 20175300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.